1. First report of manic-like symptoms in a COVID-19 patient with no previous history of a psychiatric disorder.
- Author
-
Lu S, Wei N, Jiang J, Wu L, Sheng J, Zhou J, Fang Q, Chen Y, Zheng S, Chen F, Liang T, and Hu S
- Subjects
- Antibodies, Viral cerebrospinal fluid, Antipsychotic Agents therapeutic use, Antiviral Agents therapeutic use, Betacoronavirus, Bipolar Disorder cerebrospinal fluid, Bipolar Disorder diagnosis, Bipolar Disorder drug therapy, Brain diagnostic imaging, COVID-19, COVID-19 Testing, Chest Pain, China, Clinical Laboratory Techniques, Cobicistat therapeutic use, Coronavirus Infections cerebrospinal fluid, Coronavirus Infections diagnosis, Coronavirus Infections therapy, Darunavir therapeutic use, Dyspnea, Fever, Glucocorticoids therapeutic use, Humans, Indoles therapeutic use, Magnetic Resonance Imaging, Male, Methylprednisolone therapeutic use, Middle Aged, Moxifloxacin therapeutic use, Olanzapine therapeutic use, Pandemics, Pharyngitis, Pneumonia, Viral cerebrospinal fluid, Pneumonia, Viral diagnosis, Pneumonia, Viral therapy, Reverse Transcriptase Polymerase Chain Reaction, SARS-CoV-2, Bipolar Disorder etiology, Coronavirus Infections complications, Pneumonia, Viral complications
- Abstract
Background: In December 2019, the novel coronavirus (SARS-CoV-2) infection was first reported in Wuhan city, central China, which has spread rapidly. The common clinical features of patients with SARS-CoV-2 infection included fever, fatigue, and damage to the respiratory or digestive system. However, it is still unclear whether SARS-CoV-2 infection could cause damage to the central nervous system (CNS) inducing psychiatric symptoms., Case Report: Herein, we present the first case of SARS-CoV-2 infection with manic-like symptoms and describe the diagnosis, clinical course, and treatment of the case, focusing on the identifications of SARS-CoV-2 in the specimen of cerebrospinal fluid (CSF). The patient developed manic-like symptoms when his vital signs recovered on illness day 17. After manic-like attack, the detection of SARS-CoV-2 specific IgG antibody in CSF was positive, while the reverse transcriptase-polymerase chain reaction (RT-PCR) on CSF for the SARS-CoV-2 was negative. The patient received Olanzapine for treatment and his mood problems concurrently improved as indicated by scores of Young Manic Rating Scale (YMRS)., Limitation: This is a single case report only, and the RT-PCR test for SARS-CoV-2 in CSF was not performed simultaneously when SARS-CoV-2 was positive in samples of sputum and stool., Conclusion: This first case of COVID-19 patient with manic-like symptoms highlights the importance of evaluation of mental health status and may contribute to our understanding of potential risk of CNS impairments by SARS-CoV-2 infection., (Copyright © 2020. Published by Elsevier B.V.)
- Published
- 2020
- Full Text
- View/download PDF